What is Anna Magee's NPI number?

Anna Magee's National Provider Identifier (NPI) is 1962466334, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Anna Magee's specialty?

Anna Magee is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Anna Magee located?

Anna Magee's practice location on file with NPPES is 600 Peter Jefferson Parkway, Charlottesville, VA 22911-8835.

What is Anna Magee's phone number?

The practice phone number listed in the NPPES registry for Anna Magee is (434) 984-2400.

Does Anna Magee accept Medicare?

Anna Magee is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Anna Magee's NPI active?

Yes — Anna Magee's NPI (1962466334) is active in the NPPES registry as of the last update on 2008-10-14.

IndividualActiveAccepts Medicare

Anna Magee, MD

NPI 1962466334 · Dermatology Physician · Charlottesville, VA

Anna Magee, MD is a Dermatology Physician provider in Charlottesville, VA (NPI 1962466334).

Provider details

NPI number: 1962466334
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: Yes
License: 0101051293 (VA)

Practice location

600 Peter Jefferson Parkway

Suite 230

Charlottesville, VA 22911-8835

Phone: (434) 984-2400

Fax: (434) 984-1147

Street-level locationGet directions

More VA providers

Mailing address

600 Peter Jefferson Parkway

Charlottesville, VA 22911-8835

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 0101051293 (VA)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(94/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
7,677 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,822	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,703	$88
Destruction of Precancer Skin Growth, 1 Growth17000	1,198	$52
Biopsy of Related Skin Growth, First Growth11102	711	$88
Destruction of Skin Growth, 1-14 Growths17110	616	$109
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 18 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	163	124
Fluorouracil	131	124
Clobetasol Propionate	85	57
Ketoconazole	61	34
Hydrocortisone	47	35
Metronidazole	45	30
Doxycycline Hyclate	34	30
Fluocinolone/Shower Capbrand: Fluocinolone Acetonide	32

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$6,120 across 18 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-04-13
Last updated: 2008-10-14

Frequently asked questions

What is Anna Magee's NPI number?: Anna Magee's National Provider Identifier (NPI) is 1962466334, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Anna Magee's specialty?: Anna Magee is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Anna Magee located?: Anna Magee's practice location on file with NPPES is 600 Peter Jefferson Parkway, Charlottesville, VA 22911-8835.
What is Anna Magee's phone number?: The practice phone number listed in the NPPES registry for Anna Magee is (434) 984-2400.
Does Anna Magee accept Medicare?: Anna Magee is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Anna Magee's NPI active?: Yes — Anna Magee's NPI (1962466334) is active in the NPPES registry as of the last update on 2008-10-14.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,822	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,703	$88
Destruction of Precancer Skin Growth, 1 Growth17000	1,198	$52
Biopsy of Related Skin Growth, First Growth11102	711	$88
Destruction of Skin Growth, 1-14 Growths17110	616	$109
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 18 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	163	124
Fluorouracil	131	124
Clobetasol Propionate	85	57
Ketoconazole	61	34
Hydrocortisone	47	35
Metronidazole	45	30
Doxycycline Hyclate	34	30
Fluocinolone/Shower Capbrand: Fluocinolone Acetonide	32

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$6,120 across 18 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments